AI assistant
Sending…
CLOROX CO /DE/ — Director's Dealing 2009
Jun 12, 2009
30403_dirs_2009-06-12_8f90178f-eb1c-43a8-a796-8eb662d82540.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2009-06-02
Reporting Person: Britanik Thomas P (SVP-Chief Marketing Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 8758 | Direct |
| Common Stock | 4.6 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $35.22 | 2011-09-24 | Common Stock (7740) | Direct | |
| Stock Option (Right to Buy) | $36.13 | 2010-09-20 | Common Stock (5570) | Direct | |
| Stock Option (Right to Buy) | $40.18 | 2012-10-01 | Common Stock (6573) | Direct | |
| Stock Option (Right to Buy) | $45.87 | 2013-09-17 | Common Stock (5610) | Direct | |
| Stock Option (Right to Buy) | $52.7 | 2014-09-28 | Common Stock (7480) | Direct | |
| Stock Option (Right to Buy) | $55.72 | 2015-07-01 | Common Stock (3452) | Direct | |
| Stock Option (Right to Buy) | $57 | 2015-09-21 | Common Stock (11300) | Direct | |
| Stock Option (Right to Buy) | $61.16 | 2017-09-18 | Common Stock (16400) | Direct | |
| Stock Option (Right to Buy) | $61.51 | 2016-09-19 | Common Stock (13000) | Direct | |
| Stock Option (Right to Buy) | $63.95 | 2018-09-16 | Common Stock (19180) | Direct |
Footnotes
F1: Option vests in 3 equal installments - 1/3 on each of the first, second and third anniversaries of the grant date.
F2: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date.
More from CLOROX CO /DE/
Regulatory Filings
2026
Jun 1
Board/Management Information
2026
May 28
Capital/Financing Update
2026
May 11
Regulatory Filings
2026
May 8
Capital/Financing Update
2026
May 6
Capital/Financing Update
2026
May 6
Capital/Financing Update
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29